Coagulation Testing Quality
Conference Agenda
3rd Conference
April 14-17, 2009
1st Workshop
April 15-16, 2009
Minneapolis Marriott City Center Hotel
Minneapolis, Minnesota
Tuesday, April 14, 2009
| 7:00-8:00 AM | Registration and Breakfast Marriott Minneapolis City Center Hotel, 4th Floor Lobby |
| Session I: Quality in Laboratory Hemostasis and Thrombosis Moderator: John D. Olson, MD, PhD |
|
| 7:55-8:00 AM | Welcome and Introduction - Ballroom 1 William L. Nichols, MD |
| 8:00-8:30 AM | General Quality Planning in the Hemostasis Laboratory John D. Olson, MD, PhD |
| 8:30-9:00 AM | Hemostasis Test Validation, Performance and Reference Intervals Richard A. Marlar, PhD |
| 9:00-9:30 AM | Sample Integrity and Preanalytical Variables Dorothy M. (Adcock) Funk, MD |
| 9:30-10:00 AM | Internal Quality Control in the Hemostasis Laboratory Steve Kitchen, PhD |
| 10:00-10:30 AM | Break (Exhibits Open) |
| 10:30-11:00 AM | External Quality Assessment in Hemostasis: Its Importance and Significance F. Eric Preston, MD |
| 11:00-11:30 AM | Initial Evaluation of Hemostasis: Reagent and Method Selection Wayne L. Chandler, MD |
| 11:30-12:15 PM | Questions and Panel Discussion Faculty |
| 12:15-1:45 PM | Luncheon Marriott Ballroom 2 |
Session II: Laboratory Quality Organizations: Updates About New Initiatives and Programs
Moderator: Piet Meijer, PhD
| 1:45-2:05 PM | EQATH: Passing and Failing PT/EQA – Results of an EQATH Survey John D. Olson, MD, PhD |
| 2:05-2:25 PM | QMP-LS: A Canadian Regional EQA Program – How Labs Get In and Out of Trouble in Ontario Anne Raby, MLT, ART |
| 2:25-2:45 PM | ECAT: New EQA Initiatives – Factor XIII, Fibrinolysis, Heparin Piet Meijer, PhD |
| 2:45-3:05 PM | UK-NEQAS: What’s New? - EQA for Heparin-Induced Thrombocytopenia (HIT) Testing and LMWH (Low Molecular Weight Heparin) Assays Steve Kitchen, PhD |
| 3:05-3:35 PM | Break (Exhibits Open) |
| 3:35-3:55 PM | NASCOLA’s New Studies and Initiatives – Burning Questions, and Networking to Find Answers Catherine P.M. Hayward, MD, PhD |
| 3:55-4:15 PM | CLSI: Highlights of New Guidelines for Hemostasis Testing |
| 4:15-4:35 PM | CAP: Results from New EQA Initiatives – HIT, Heparin, Thrombophilia Elizabeth M. Van Cott, MD |
| 4:35-5:15 PM | Panel Discussion and Questions |
| 5:15 PM | Adjourn |
| 6:00-8:00 PM | Conference Reception with Hemostasis Product Display and Poster Viewing Marriott Fourth Floor Lobby |
Wednesday, April 15, 2009
| 7:00-8:30 AM | Breakfast Marriott Fourth Floor Lobby |
| 7:30-8:30 AM | Breakfast-with-the-Experts (Simultaneous sessions, repeated on Thursday; pre-registration required) Session 1: Pediatric Hemostatic Disorders and Testing: A Case-Based Discussion - Crystal Lake Room Session 2: Heparin-Induced Thrombocytopenia (HIT) and Laboratory Testing - Ballroom 1 Session 3: Optimizing Testing for Platelet Disorders – The Nitty Gritty of What We Do - Deer Lake Room Session 4: Validating New or Revised Diagnostic Tests - Elk Lake Room |
| 8:40 AM | Announcements and Updates - Ballroom 1 |
Session III: Platelet Functional Disorders and Testing
Moderator: James L. Zehnder, MD
| 8:45-9:30 AM | Platelet Electron Microscopy for Diagnosis of Platelet Disorders James G. White, MD |
| 9:30-10:00 AM | NASCOLA / ECAT Platelet Aggregometry Interpretive Survey and Proficiency Exercise for Dense Granule Deficiency Evaluation Catherine P.M. Hayward, MD, PhD |
| 10:00-10:30 AM | Flow Cytometry for Evaluation of Platelet Disorders Dong Chen, MD, PhD |
| 10:30-11:00 AM | Break (Exhibits and Posters Open) |
| 11:00-11:30 AM | Heparin-Induced Thrombocytopenia (HIT) Laboratory Testing: Results of a New ECAT EQA Initiative Piet Meijer, PhD |
| 11:30-12:00 PM | Panel Discussion and Questions |
| 12:00-1:30 PM | Luncheon |
Session IV: Coagulation Workshop 1: Platelet Functional Disorders and Testing
SPRING TRAINING: Instrument & Reagent Presentations (Pre-registration Required)
Moderator: William L. Nichols, MD
Presentations by Platelet-related Diagnostics/Instruments/Reagents Companies (Companies to provide speaker)
| 1:30 PM | Workshop Opening Comments William L. Nichols, MD |
| 1:35-2:00 PM | Whole Blood Platelet Aggregation in Clinical Practice |
| 2:00-2:25 PM | PFA-100 Testing: Clinical Indications Donna D. Castellone, MS, MT(ASCP)SH Clinical Project Manager Hemostasis/Hematology Siemens Healthcare Diagnostics Tarrytown, New York Sponsored by Siemens Healthcare Diagnostics |
| 2:25:2:40 PM | The Technique of Platelet Whole Mount Electron Microscopy for Dense Granule Enumeration: A Video Demonstration James G. White, MD |
| 2:40-2:50 PM | Panel Discussion and Questions |
| 2:50-3:30 PM | Break (Exhibits and Posters Open) |
Workshop: Case-based testing & clinical presentations
Moderator: William L. Nichols, MD
(Faculty Presentations)
| 3:30-4:00 PM | Case A Catherine P.M. Hayward, MD, PhD |
| 4:00-4:30 PM | Case B William L. Nichols, MD |
| 4:30-5:00 PM | Case C Dong Chen, MD, PhD |
| 5:00 PM | Adjourn (No pre-scheduled evening conference activities) |
Thursday, April 16, 2009
| 7:00-8:30 AM | Breakfast Marriott Fourth Floor Lobby |
| 7:30-8:30 AM | Breakfast-with-the-Experts (Simultaneous sessions, repeated from Wednesday; pre-registration required) Session 1: Pediatric Hemostatic Disorders and Testing: A Case-Based Discussion - Crystal Lake Room Session 2: Heparin-Induced Thrombocytopenia (HIT) and Laboratory Testing - Ballroom 1 Session 3: Optimizing Testing for Platelet Disorders – The Nitty Gritty of What We Do - Deer Lake Room Session 4: Validating New or Revised Diagnostic Tests - Elk Lake Room |
| 8:40 AM | Announcements and Updates - Ballroom 1 |
Session V: Von Willebrand Factor/Disease (VWF/VWD) and Factor VIII Inhibitors
Moderator: Ellinor I.B. Peerschke, PhD
| 8:45-9:10 AM | Laboratory Diagnosis of VWD: The 2008 NHLBI Guidelines William L. Nichols, MD |
| 9:10-9:30 AM | VWF/VWD Testing Practices: NASCOLA Survey Results Wayne L. Chandler, MD |
| 9:30-10:00 AM | Clinical and Laboratory Aspects of Factor VIII Inhibitors: An Overview Georges E. Rivard, MD |
| 10:00–10:30 AM | Break (Exhibits and Posters Open) |
| 10:30–11:00 AM | Factor VIII Inhibitor Testing: Nijmegen Modifications, Experience and Recommendations Bert Verbruggen, PhD |
| 11:00-11:20 AM | Factor VIII Inhibitor Evaluation: Mayo Clinic Approach & New Information Rajiv K. Pruthi, MBBS |
| 11:20-11:35 AM | NASCOLA Proficiency Testing Results for Factor VIII Inhibitors Ellinor I.B. Peerschke, PhD |
| 11:35-12:10 PM | Panel Discussion and Questions |
| 12:10-1:30 PM | Luncheon Marriott Ballroom 2 |
Session VI: Coagulation Workshop 2: Coagulation Disorders and Testing
Spring Training: Instrument & reagent presentations (Pre-registration Required)
Moderator: Rajiv K. Pruthi, MBBS
Presentations by Coagulation-related Diagnostics/Instruments/Reagents Companies (Companies to provide speaker)
| 1:30 PM | Workshop Opening Comments Rajiv K. Pruthi, MBBS |
| 1:35-2:00 PM | Innovations in Monitoring Anticoagulant Therapies Jim F. DeMase Marketing Manager - Hemostasis Beckman Coulter, Inc. Brea, California Sponsored by Beckman Coulter / Instrumentation Laboratory |
| 2:00-2:25 PM | New Technologies in Coagulation from GTI Diagnostics: VWF & Propeptide Assay & FVIII Antibody Screen Dave Boyer Product Manager - New Technology Assessment GTI Diagnostics Waukesha, Wisconsin Sponsored by GTI Diagnostics |
| 2:25-2:50 PM | Procoagulant Phospholipid Gwyn A. Cutsforth, MT(ASCP), PhD Clinical & Scientific Research Manager Diagnostica Stago, Inc. Parsippany, New Jersey Sponsored by Diagnostica Stago, Inc. |
| 2:50-3:00 PM | Panel Discussion and Questions |
| 3:00-3:30 PM | Break (Exhibits and Posters Open) |
Workshop: Case-based testing & clinical presentations
Moderator: Rajiv K. Pruthi, MBBS (Faculty Presentations)
| 3:30-4:00 PM | Case A Rajiv K. Pruthi, MBBS |
| 4:00-4:30 PM | Case B Layna K. Cardel, BS, MT(ASCP) |
| 4:30-5:00 PM | Case C Elizabeth M.Van Cott, MD |
| 5:00 PM | Adjourn (No pre-scheduled evening conference activities) |
Friday, April 17, 2009
| 6:45-7:55AM | Breakfast (Marriot 4th Floor) |
Session VII: Coagulation Testing Potpourri
Moderator: Dong Chen, MD, PhD
| 7:55 AM | Announcements - Ballroom 1 |
| 8:00-8:30 AM | External Quality Assessment of Point-of-Care Testing (POCT) Devices in Hemostasis Including ACT, ROTEM and TEG Steve Kitchen, PhD |
| 8:30-8:45 AM | Abstract #1: Evaluation of the Haemonetics TEG® 5000 Platelet Mapping™ Method Suzanne M. Hoffman, MT(ASCP) Special Coagulation Laboratory University of Wisconsin Hospital and Clinics Madison, Wisconsin |
| 8:45-9:15 AM | EQA Assessment Incorporating Biological Variation Piet Meijer, PhD |
| 9:15-9:30 AM | Abstract #2: A Regional Quality Assurance Program for Core Coagulation Laboratories Karen A. Moffat, MLT, ART, FCSMLS(D) |
| 9:30-10:00 AM | D-Dimer Assay Issues and Standardization: QMP-LS Studies Anne Raby, MLT, ART |
| 10:00-10:30 AM | Break |
| 10:30-11:00 AM | Laboratory Monitoring of Heparin Anticoagulation: Current Issues and Recommendations Marilyn A. Johnston, MLT, ART |
| 11:00-11:15 AM | Abstract #3: Evaluation of an Alternate Activating Reagent for the Performance of Coagulation Factor Assays in the Presence of Lupus Anticoagulants John Barranco, MT(ASCP) Florida Hospital Center for Thrombosis Research Orlando, Florida |
| 11:15-11:30 AM | Abstract #4: Laboratory Evaluation of an Automated Latex von Willebrand Factor Activity Assay Julie I. Tange, BS Special Coagulation Laboratory Mayo Clinic Rochester, Minnesota |
| 11:30-12:00 PM | Panel Discussion and Questions |
| 12:00 PM | Adjourn (Box lunches available) |
External
link
PDF
document
Excel
document
Word
document